Table 4.
Distribution of IgG antibodies against S1/S2 SARS-CoV-2 positivity and clinical comorbidities.
Variables | Positives | ||||||
---|---|---|---|---|---|---|---|
Total | X2 | p | OR | 95% CI | |||
No. | % | ||||||
IgG SARS-CoV-2 | |||||||
Diabetes | |||||||
Yes | 36 | 11.7 | 74 | 57.1 | 0.001 | 0.13 | 0.075–0.234 |
No | 272 | 88.3 | 310 | ||||
Hypertension | |||||||
Yes | 57 | 18.5 | 109 | 74.1 | 0.001 | 0.105 | 0.60–0.184 |
No | 251 | 81.5 | 275 | ||||
Total | 308 | 384 | |||||
Autoimmune Diseases | |||||||
Yes | 8 | 2.6 | 8 | ||||
No | 300 | 97.4 | 376 | ||||
Total | 308 | 384 | 0.22 | 0.168 | 1.25 | 1.19–1–31 | |
Respiratory Diseases | |||||||
Yes | 11 | 3.6 | 11 | ||||
No | 297 | 96.4 | 373 | ||||
Total | 308 | 384 | 2.7 | 0.08 | 1.25 | 1.19–1.32 | |
Cardiac Diseases | |||||||
Yes * No Total |
4 304 308 |
1.3 98.7 |
4 308 384 |
24.5 | 0.0001 | 0.17 | 0.004–0.76 |
* X2 = corrected.